Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 64 Next »

Include the following on your IRB application for your DHS research data request. If you are filing an amendment to an existing IRB application, use this as a guide.

Section 5

 Question 5.2 Full Protocol

In your study protocol in Question 5.2, in your own words, state in the Methods and Procedures section that you will be working with the DHS Informatics and Analytics Core to extract the data variables listed, which will be sourced from the DHS Clinical Data Warehouse or DHS i2b2.

Specify that the DHS Investigator(s) will take responsibility for all DHS data management, storage, transfer, and management. PHI files must be only kept within to IRB-approved study personnel with proper DHS credentials, kept within the DHS Intranet, encrypted, password-protected, and behind DHS firewalls. Be sure to enable track changes if making these protocol changes to your IRB.

Be specific in how DHS PHI will be handled behind County firewalls/DHS Intranet by only IRB-approved DHS study personnel. Provide further details on how the PI will handle DHS data management (i.e. on a password-protected Keck laptop) and if applicable, data transfer (i.e. de-identified data to REDCap)

  • Indicate which variables you plan to obtain by working with the Informatics Team and or i2b2.

  • Indicate which variables you plan to abstract by conducting further chart review.

  • Indicate if you intend to contact DHS patients using the information provided by the Informatics and Analytics core for study recruitment purposes.

Section 6

 Question 6.1 Study Locations Section

In Question 6.1, check “USC HSC Locations” and “LAC+USC Associated Locations.”

 Question 6.a.1 HSC Location(s) and/or Los Angeles General Medical Center Locations

In Question 6.a.1, check the specific DHS facilities that are applicable to your research study. This checkbox triggers the DHS research Oversight Board (ROB) research categorization process. To learn more about this process, click here.

 Question 6a.4 Los Angeles General Medical Center Studies

In Question 6a.4, select “Yes” to indicate that this research will potentially benefit DHS patients in the future. Mark the following questions in this section that best reflect your research study.

Section 9

 Question 9.1 Methods and Procedures

In Question 9.1 Methods and Procedures, check one of the “Secondary Analysis” options that is most relevant to your research. Checking one of these boxes triggers the activation of Section 13.

Section 13

 Question 13.1 Methods and Procedures - Collection of Data/Specimens

In Question 13.1, indicate “Yes” or “No” if you will be including DHS patients who are deceased. This must also be indicated in your patient cohort inclusion/exclusion criteria.

 Question 13.2 Methods and Procedures - Collection of Data/Specimens

In Question 13.2, upload a Data Collection Form which includes all of the variables you will need for the research data request (can be a Word Doc or Excel Sheet).

Please differentiate between data elements you plan to abstract from the chart and data that will be obtained using the Informatics Core team and or tools such as i2b2. If applicable, please also include a PDF of your i2b2 print query report. Please review the how-to "Print Query" article for further instruction.

 Question 13.2.1 Methods and Procedures - Collection of Data/Specimens

In Question 13.2.1, check "Yes" for use of the Clinical Data Warehouse (CDW) at LA County.  This answer will trigger Section 42.       
         

 Question 13.4 Methods and Procedures - Collection of Data/Specimens

In Question 13.4 Methods and Procedures, indicate if any identifying patient private health information (PHI) is requested. 

  • ADDRESS1 

  • ADDRESS2

  • Admit Date

  • City 

  • Discharge Date 

  • Encounter Number 

  • Medical Record Number (MRN) 

  • Name 

  • Phone 

  • State

  • Zip

Section 24

 Question 24.3 Informed consent and waivers

If the research study is submitted for exempt review, it will not have iStar Question 24.3. If NOT exempt, in Section 24.3, for “Informed consent and waivers” indicate if you will or will not require a HIPAA Waiver of Consent. 

Section 36

 Question 36 HIPAA Analysis

Please note that if DHS patient data will leave DHS premises for transfer or further analysis (i.e. entering PHI into REDCap in a Keck environment), you may need a Full HIPAA Waiver.

In Question 36.1, if you are using the CDW at DHS for RECRUITMENT purposes, indicate that you will be requesting a “Partial waiver of HIPAA.”

If you are using the CDW at DHS for medical records review only, then you should indicate in Question 36.1, “None of the above” and in section 36.2, “Full waiver of HIPAA”.

Then, for Question 36.2, select “Both” to indicate that you will be obtaining both HIPAA authorization from participant in addition to a Full Waiver (since their PHI will be obtained).

**With a Partial Waiver, you may have access to DHS PHI for study recruitment purposes. However, for recruitment studies, once the participant agrees to participate, they must ALSO consent to sign the full HIPAA authorization in order for you to use/retain any of the data accessed from the Partial Waiver.

Section 42

 Question 42 Clinical Data Warehouse

In Question 42, select which Clinical Data Warehouse(s) you will request research data from.

 Question 42.2 Clinical Data Warehouse

In Question 42.2, please indicate which PHI variables from the CDW you will require.

 Question 42.3 Clinical Data Warehouse

In Question 42.3, indicate if you plan to contact people whose data will be obtained from the CDW. Ensure that your contact methods and management of DHS PHI are clearly stated in your study protocol in Section 5.2.

Once you have received an IRB letter of approval in iStar with an ROB categorization score, aka DHS Level of Support (ranges from 1-5), you are ready to submit a data request to the DHS Informatics and Analytics Core.





  • No labels